Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug ...
JD Supra

Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies

Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for ...

2026 Regulatory Crossfire: New Outlook Survey Reveals Health IT Rules Reshaping U.S. Care Delivery

WASHINGTON, DC / ACCESS Newswire / December 9, 2025 / Black Book Research today announced the release of new survey results, 2026 U.S. Healthcare Technology Regulatory Outlook: Federal, State & Local ...